Cargando…

Risk of Short-Term Prostate-Specific Antigen Recurrence and Failure in Patients With Prostate Cancer: A Secondary Analysis of a Randomized Clinical Trial

IMPORTANCE: A shorter time interval to prostate-specific antigen (PSA) failure is associated with worse clinical outcomes; however, specific factors defining this state remain unknown. OBJECTIVE: To evaluate the factors of a short time interval to PSA failure in order to identify patients for treatm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sayan, Mutlay, Huang, Jiaming, Xie, Wanling, Chen, Ming-Hui, Loffredo, Marian, McMahon, Elizabeth, Orio, Peter, Nguyen, Paul, D’Amico, Anthony V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559177/ https://www.ncbi.nlm.nih.gov/pubmed/37801315 http://dx.doi.org/10.1001/jamanetworkopen.2023.36390

Ejemplares similares

Association of Increased Prostate-Specific Antigen Levels After Treatment and Mortality in Men With Locally Advanced vs Localized Prostate Cancer: A Secondary Analysis of 2 Randomized Clinical Trials
por: King, Martin T., et al.
Publicado: (2021)

Natural History of Untreated Prostate Specific Antigen Radiorecurrent Prostate Cancer in Men with Favorable Prognostic Indicators
por: Martin, Neil E., et al.
Publicado: (2014)

Mortality Risk for Docetaxel-Treated, High-Grade Prostate Cancer With Low PSA Levels: A Meta-Analysis
por: Mahal, Brandon A., et al.
Publicado: (2023)

Obesity and the Odds of Weight Gain following Androgen Deprivation Therapy for Prostate Cancer
por: Braunstein, Lior Z., et al.
Publicado: (2014)

Radiation therapy for prostate cancer in Syrian refugees: facing the need for change
por: Eren, Mehmet Fuat, et al.
Publicado: (2023)

Radiation and Androgen Deprivation Therapy With or Without Docetaxel in the Management of Nonmetastatic Unfavorable-Risk Prostate Cancer: A Prospective Randomized Trial
por: D'Amico, Anthony V., et al.
Publicado: (2021)

Evidence Suggesting That Obesity Prevention Measures May Improve Prostate Cancer Outcomes Using Data from a Prospective Randomized Trial
por: Chandra, Ravi A., et al.
Publicado: (2014)

Racial and Ethnic Disparities in the Use of Prostate Magnetic Resonance Imaging Following an Elevated Prostate-Specific Antigen Test
por: Abashidze, Nino, et al.
Publicado: (2021)

Association of the USPSTF Grade D Recommendation Against Prostate-Specific Antigen Screening With Prostate Cancer–Specific Mortality
por: Burgess, Laura, et al.
Publicado: (2022)

Low-Value Prostate-Specific Antigen Test for Prostate Cancer Screening and Subsequent Health Care Utilization and Spending
por: Kim, David D., et al.
Publicado: (2022)

Low-Value Prostate-Specific Antigen Screening in Older Males
por: Kalavacherla, Sandhya, et al.
Publicado: (2023)

Variation in Prostate-Specific Antigen Testing Rates and Prostate Cancer Treatments and Outcomes in a National 20-Year Cohort
por: Bergengren, Oskar, et al.
Publicado: (2021)

Cost-Effectiveness of Annual Prostate MRI and Potential MRI-Guided Biopsy After Prostate-Specific Antigen Test Results
por: Yun, Hyunkyung, et al.
Publicado: (2023)

Association of Baseline Prostate-Specific Antigen Level With Long-term Diagnosis of Clinically Significant Prostate Cancer Among Patients Aged 55 to 60 Years: A Secondary Analysis of a Cohort in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
por: Kovac, Evan, et al.
Publicado: (2020)

Obesity inversely correlates with prostate-specific antigen levels in a population with normal screening results of prostate cancer in northwestern China
por: Zhang, J., et al.
Publicado: (2016)

Variations in Age-Adjusted Prostate Cancer Incidence Rates by Race and Ethnicity After Changes in Prostate-Specific Antigen Screening Recommendation
por: Lai, Sue-Min, et al.
Publicado: (2022)

The Importance of Prostate-Specific Membrane Antigen Expression in Carotid Body Paragangliomas
por: Yasan, Hasan, et al.
Publicado: (2021)

The Importance of Prostate-Specific Membrane Antigen Expression in Salivary Gland Tumors
por: Sivrice, Mehmet Emre, et al.
Publicado: (2022)

Prostate-Specific Membrane Antigen Expression on PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer: A Retrospective Observational Study
por: Calderoni, Letizia, et al.
Publicado: (2023)

Association Between Antidiabetic Medications and Prostate-Specific Antigen Levels and Biopsy Results
por: Beckmann, Kerri, et al.
Publicado: (2019)

(177)Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer and Prior (223)Ra (RALU Study)
por: Rahbar, Kambiz, et al.
Publicado: (2023)

SAT-500 Osteoblastic Metastasis in Prostate Cancer: A Sink Trap for Calcium in a Patient with Concomitant Secondary Hyperparathyroidism and Metastatic Prostate Cancer
por: Zeng, Wanling, et al.
Publicado: (2019)

Prostate-Specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of Death
por: Tilki, Derya, et al.
Publicado: (2023)

Thrombotic microangiopathy secondary to recurrent prostate cancer
por: Newton, Joseph, et al.
Publicado: (2021)

Conditional Risks of Biochemical Failure and Prostate Cancer–Specific Death in Patients Undergoing External Beam Radiotherapy: A Secondary Analysis of 2 Randomized Clinical Trials
por: Alexander, Gregory S., et al.
Publicado: (2023)

Prostate-Specific Antigen and Prostate-Specific Antigen Velocity as Threshold Indicators in (11)C-Acetate PET/CTAC Scanning for Prostate Cancer Recurrence
por: Dusing, Reginald W., et al.
Publicado: (2014)

Association of Prostate-Specific Antigen Velocity With Clinical Progression Among African American and Non-Hispanic White Men Treated for Low-Risk Prostate Cancer With Active Surveillance
por: Nelson, Tyler J., et al.
Publicado: (2021)

Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography–Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer
por: Xiang, Michael, et al.
Publicado: (2021)

Association of β-Blocker Use at Time of Radical Prostatectomy With Rate of Treatment for Prostate Cancer Recurrence
por: Sivanesan, Shivanthe, et al.
Publicado: (2022)

Association of Bone Metastatic Burden With Survival Benefit From Prostate Radiotherapy in Patients With Newly Diagnosed Metastatic Prostate Cancer: A Secondary Analysis of a Randomized Clinical Trial
por: Ali, Adnan, et al.
Publicado: (2021)

Association of Neighborhood Deprivation With Prostate Cancer and Immune Markers in African American and European American Men
por: Pichardo, Margaret S., et al.
Publicado: (2023)

Presence of HPV in prostate tissue from patients submitted to prostate biopsy
por: Pereira, Nalisson Marques, et al.
Publicado: (2023)

Defining Prostatic Vascular Pedicle Recurrence and the Anatomy of Local Recurrence of Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography
por: Dundee, Philip, et al.
Publicado: (2022)

Overexpression of claspin promotes docetaxel resistance and is associated with prostate‐specific antigen recurrence in prostate cancer
por: Babasaki, Takashi, et al.
Publicado: (2021)

Prior-Cancer Diagnosis in Men with Nonmetastatic Prostate Cancer and the Risk of Prostate-Cancer-Specific and All-Cause Mortality
por: Mirabeau-Beale, Kristina, et al.
Publicado: (2014)

Hyaluronic Acid Spacer for Hypofractionated Prostate Radiation Therapy: A Randomized Clinical Trial
por: Mariados, Neil F., et al.
Publicado: (2023)

Prostate Artery Embolization for Complete Urinary Outflow Obstruction Due to Benign Prostatic Hypertrophy
por: Yu, Simon Chun Ho, et al.
Publicado: (2016)

Preferences for More or Less Health Care and Association With Health Literacy of Men Eligible for Prostate-Specific Antigen Screening in Australia
por: Pickles, Kristen, et al.
Publicado: (2021)

Co-expression and impact of prostate specific membrane antigen and prostate specific antigen in prostatic pathologies
por: Ben Jemaa , Awatef, et al.
Publicado: (2010)

Urinary Outcomes for Men With High Baseline International Prostate Symptom Scores Treated With Prostate SBRT
por: Gorovets, Daniel, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lut55n55qjtorclfbin8m3np5n